VMware Horizon Desktops

VMware Horizon Drives Demand for More Chrome Devices in Healthcare

Chrome devices in healthcare

As HIMSS descends upon us again this year, VMware will once again be showcasing how VMware healthcare solutions are transforming the care provider and patient experience (check out this blog on VMware EUC at HIMSS). Following the announcement that VMware Airwatch has been awarded Category Leader: EMM/MDM in the 2018 Best in KLAS Software and Services Report, we will be showcasing our Digital Clinical Workspace and Point of Care solutions.

As virtual desktops increasingly prove their value in healthcare, VMware Horizon is becoming the platform of choice to deliver EMR’s including Epic and Cerner, providing nonstop access to clinical desktops, point-of-care applications and the freedom to work from anywhere, on any device. For the first time, we will be demonstrating how Chromebooks can provide secure access to VMware Horizon and underlying EMR solutions while reducing the overall cost to your organization.

Why Google Chrome Enterprise? Chromebooks, running on Chrome OS, are emerging in the enterprise as a secure, cloud first device with a TCO significantly less than alternatives. IDC estimates that by 2018, 25% of Fortune 500 companies will have IT-supported Chromebooks deployed in their organization. Last year, we announced management support for Chrome OS and today we have many customers using it reliably with good performance.

VMware continues to work hard to support different endpoints and operating systems on our Horizon Client, giving our customers the flexibility to purchase a myriad of low cost and secure devices to access their secure cloud desktop and apps.

Come to the VMware (#3803) or the Google booth (#2829) at HIMSS, to view a live demo of a Digital Clinical Workspace powered by Horizon 7, Workspace ONE and a Chrome OS endpoint. Make sure to stop by the Google Cloud booth Wednesday at 2:30 PM for a live demo of Horizon on a Chrome.

Stay tuned for updates on VMware Horizon by subscribing to our blog, and following us on Twitter and Facebook.